Catalyst Wire Dossier Catalyst Wire Dossier

VASOSTRICT

vasopressin · Par Health USA, LLC
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for VASOSTRICT, covering 2014-04-17 to 2023-04-12. Get the full timeline:

Most recent: FDA Approved: VASOSTRICT — Supplemental Application (Par Health USA, LLC)

See pricing